Nasim H Karimi

A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease

I. Almeida, Katja Michael, O. Moreira, 2019, npj Vaccines.

Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins

A. M. Carvalho, I. Almeida, E. Carvalho, 2022, Emerging microbes & infections.

Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of α-Gal-Containing Neoglycoproteins: Application as Biomarkers for Reliable Diagnosis and Early Assessment of Chemotherapeutic Outcomes of Chagas Disease.

I. Almeida, J. Gascón, L. Izquierdo, 2019, Methods in molecular biology.

A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease

I. Almeida, Katja Michael, O. Moreira, 2019, npj Vaccines.